{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:12:23Z","timestamp":1781579543945,"version":"3.54.5"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,15]]},"DOI":"10.2169\/internalmedicine.9121-21","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T22:10:03Z","timestamp":1650665403000},"page":"3699-3702","source":"Crossref","is-referenced-by-count":5,"title":["Usefulness of Dapagliflozin for Nephrotic Syndrome Secondary to Diabetic Kidney Disease"],"prefix":"10.2169","volume":"61","author":[{"given":"Ryoko","family":"Murashima","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiryu","family":"Sai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Tagawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Metabolism, and Endocrinology, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yanagawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaki","family":"Ishiwata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Japan"},{"name":"Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Japan"},{"name":"Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Shlipak MG, Tummalapalli SL, Boulware LE, et al.; Conference Participants. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 99: 34-47, 2021."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yokoyama H, Sugiyama H, Sato H, et al.; Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 16: 903-920, 2012.","DOI":"10.1007\/s10157-012-0593-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Singh D, Shrestha K, Testani JM, et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 20: 392-399, 2014.","DOI":"10.1016\/j.cardfail.2014.03.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Glassock RJ. Attending rounds: an older patient with nephrotic syndrome. Clin J Am Soc Nephrol 7: 665-670, 2012.","DOI":"10.2215\/CJN.12771211"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wanner C, Inzucchi SE, Lachin JM, et al.; EMPA-REG OUTCOME Investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375: 323-334, 2016.","DOI":"10.1056\/NEJMoa1515920"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. McMurray JJV, Wheeler DC, Stef\u00e1nsson BV, et al.; DAPA-CKD Trial Committees and Investigators. Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease. Circulation 143: 438-448, 2021.","DOI":"10.1161\/CIRCULATIONAHA.120.051675"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Perkovic V, Jardine MJ, Neal B, et al.; CREDENCE Trial Investigators. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380: 2295-2306, 2019.","DOI":"10.1056\/NEJMoa1811744"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tanaka A, Nakamura T, Sato E, Node K. Therapeutic potential of tofogliflozin on nephrotic syndrome secondary to diabetic nephropathy. J Cardiol Cases 16: 30-33, 2017.","DOI":"10.1016\/j.jccase.2017.04.003"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia 61: 2108-2117, 2018.","DOI":"10.1007\/s00125-018-4670-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_9121-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:30:58Z","timestamp":1715315458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/24\/61_9121-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":9,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9121-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"9121-21"}}